Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TRIM5 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
mRNA | MCAM | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
mRNA | TNK1 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
mRNA | GNAO1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | TP53I11 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
mRNA | PTH1R | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
mRNA | TAGLN3 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
mRNA | RPL7L1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
mRNA | CAMK2B | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
mRNA | BBS10 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |